Muutke küpsiste eelistusi

Treatment of Refractory Renal Anemia: Case Collection 2026 ed. [Kõva köide]

Edited by
  • Formaat: Hardback, 207 pages, kõrgus x laius: 235x155 mm, 52 Illustrations, color; 7 Illustrations, black and white; XVI, 207 p. 59 illus., 52 illus. in color., 1 Hardback
  • Ilmumisaeg: 19-Mar-2025
  • Kirjastus: Springer Nature
  • ISBN-10: 981977635X
  • ISBN-13: 9789819776351
Teised raamatud teemal:
  • Kõva köide
  • Hind: 48,70 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 57,29 €
  • Säästad 15%
  • Raamatu kohalejõudmiseks kirjastusest kulub orienteeruvalt 2-4 nädalat
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Formaat: Hardback, 207 pages, kõrgus x laius: 235x155 mm, 52 Illustrations, color; 7 Illustrations, black and white; XVI, 207 p. 59 illus., 52 illus. in color., 1 Hardback
  • Ilmumisaeg: 19-Mar-2025
  • Kirjastus: Springer Nature
  • ISBN-10: 981977635X
  • ISBN-13: 9789819776351
Teised raamatud teemal:

Renal anemia, one of the common complications in patients with chronic kidney disease, has a high prevalence and seriously affects the quality of life and prognosis of patients. This open access book provides advanced information on clinical management of renal anemia in difficult situations, which respond poorly to the existing treatment of recombinant human erythropoietin, iron and blood transfusion. Details of treatment of renal anemia in different types of patients are presented with comments from renowned nephrologist. It will be an ideal reference for practitioners and other healthcare professionals interested in learning more about renal anemia.

Part I: ESA hyporesponsive CKD anemia.
Chapter 1 Treatment of a patient
with severe anemia and systemic lupus erythematosus.
Chapter 2 Application
of roxadustat in a patient with renal anemia.- Chapter 3 Roxadustat on renal
anemia in patients with maintenance hemodialysis.- Chapter 4 Treatment of
renal anemia in a peritoneal dialysis patient with low erythropoietic
response.- Chapter 5 Treatment of anemia in a multiple myeloma patient with
deep vein thrombosis in lower limb.
Chapter 6 Treatment of a Patient with
Peritoneal Dialysis Combined with Erythropoietin-hyporesponsive Anemia.-
Chapter 7 Roxadustat for the treatment of erythropoietin-hyporesponsive
anemia in a hemodialysis patient: A case report.- Part II: CKD anemia with
PRCA.
Chapter 8 Anti-erythropoietin antibody-mediated pure red cell
aplasia.
Chapter 9 Treatment of erythropoietin-induced pure red cell
aplastic anemia.- Part III: CKD anemia with inflammation or infection.-
Chapter 10 Anemia treatment with roxadustat in a peritoneal dialysis patients
during Omicron virus infection: A case report.
Chapter 11 Use of a
hypoxia-inducible factor prolyl hydroxylase inhibitor in a peritoneal
dialysis patient with coronavirus disease 2019.
Chapter 12 Treatment of
severe anemia in a patient with acute peritonitis undergoing hemodialysis
combined with peritoneal dialysis.
Chapter 13 Erythropoietin was used to
treat anemia in a patient on maintenance hemodialysis.
Chapter 14 COVID-19
exacerbated renal anemia in a maintenance hemodialysis patient.
Chapter 15
Treatment of Anemia Complicated with Severe Infection in a He-modialysis
Patient.
Chapter 16 Treatment of renal anemia in a patient undergoing
maintenance heemodialysis who had viral hepatitis B infection.
Chapter 17
Treatment of renal anemia due to chronic interstitial nephritis.- Part IV:
CKD anemia combined with other complex disease .
Chapter 18 Treatment of
severe anemia in a hemodialysis patient with bone marrow hypoplasia.
Chapter
19 Treatment of severe renal anemia in a hemodialysis patient with
decompensation of liver cirrhosis and irregular positive erythrocyte
antibody.
Chapter 20 Treatment of anemia in a lupus nephritis patient with
renal insufficiency, infection and bone marrow hypoplasia.
Chapter 21 Effect
of roxadustat on glucose and lipid metabolism in a patient on peritoneal
dialysis with renal anemia.- Chapter 22 Treatment of renal anemia with
chronic blood loss in peritoneal dialysis patients.
Chapter 23 A case of
cardiorenal anemia syndrome complicated with malignant hypertension.
Chapter
24 Roxadustat in the treatment of renal anemia in a hemodialysis patient.-
Chapter 25 Roxadustat quickly corrected anemia in a peritoneal dialysis
patient and increased perioperative safety.
Chapter 26 Roxadustat for the
treatment of refractory anemia in a hemodialysis patient: A case report.-
Chapter 27 Treatment of anemia in a patient with chronic kidney disease and
cerebral infarction.
Chapter 28 Treatment of refractory anemia in a patient
with end-stage renal disease and a postoperative bladder tumor.
Chapter 29
The role of intravenous iron supplementation in the treatment of renal anemia
with roxadustat.
Chapter 30 Roxadustat for anemia in a patient with chronic
kidney disease not receiving dialysis.
Chapter 31 Treatment of severe anemia
in a MPO-ANCA and anti-GBM double-seropositive patient.
Chapter 32 Is
roxadustat responsible for the jaundice of a dialysis patient with
-thalassemia? A case report.
Chapter 33 One case of peritoneal dialysis
complicated with refractory hyper-tension and renal anemia.
Chapter 34
Roxadustat Corrects Acute Phosphate Nephropathy with Concur-rent Renal
Anemia: A Case Report.
Chapter 35 One patient with renal anemia complicated
with hyperferritinemia.
Bi-Cheng Liu is a Chair Professor and Dean of School of Medicine, head of Insitute  of  Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China. He is also the Vice President of Chinese Society of Nephrology and Vice President of Chinese Society of Renal Physiology.